Questions on Covid monoclonals and BA.2; CDC tones down opioid prescribing guidelines

Conflicting reports are raising questions about whether the Covid monoclonal antibody sotrovimab maintains its power against BA.2. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by        Conflicting reports raise questions about whether any monoclonals work against Omicron's sister variant By Andrew Joseph Finnbarr Webster/Getty Images Conflicting reports are raising questions about whether the Covid monoclonal antibody sotrovimab maintains its power against BA.2. Read More In a victory for pain experts, CDC tones down its opioid prescribing guidelines By Andrew Joseph Adobe Health officials abandoned their recommendations that opioid prescribers should aim for certain dose thresholds when treating chronic pain. Read More STAT+: As data sharing ramps up, health insurers wade into patient privacy debate By Mohana Ravindranath Adobe AHIP, the country's most powerful insurance lobbying group is calling on Congress to expand patient data privacy protections. Read More Sponsor content by AMERICAN CANCER SOCIETY Over 2 million people are missing out on the care they need. Close the Medicaid coverage gap. Increased access to health coverage through Medicaid expansion has resulted in earlier stage cancer diagnosis and improved survival rates. More than 2 million people — the majority of whom are people of color — are missing out on the care they need because of hurdles to affordable, comprehensive health coverage in non-expansion states. It's time for all Americans to have equitable access to care. Congress, close the coverage gap to remove hurdles to cancer care. STAT+: Senate pushes toward a vote on Robert Califf, Biden's pick for FDA By Rachel Cohrs Win McNamee/Getty Images The Biden administration and Senate Majority Leader Chuck Schumer are charging ahead with a vote on Biden’s pick to lead the FDA. Read More STAT+: Biogen pushes back on Medicare's limits on Alzheimer's drug coverage — and advances a counteroffer By Nicholas Florko Ruby Wallau for STAT Biogen has a new proposal: the company will get Medicare the extra data it wants on Aduhelm, but not through the slow trials it proposed. Read More Drugs based on next-generation gene editing are moving toward the clinic faster than CRISPR 1.0 By Megan Molteni Adobe The explosion of interest in CRISPR accelerated the movement of new and better gene editing approaches toward the clinic. Read More Opinion: There's no autism epidemic. But there is an autism diagnosis epidemic By Rachel Burr Gerrard Adobe Rising rates of children with autism is due to sociological and political factors increasing diagnoses and documentation of this condition. Read More Listen: Eric Lander's resignation, FDA's about-face, & Pfizer's lucrative pandemic By Damian Garde and Meg Tirrell and Adam Feuerstein We discuss the scandalous end of Eric Lander's tenure as presidential science adviser with STAT's Lev Facher and Megan Molteni. Read More Thursday, February 10, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser